The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Yasuhiro Kodera

Department of Surgery II

Nagoya University Graduate School of Medicine

63 Tsurumai-cho

Showa-ku

Japan

[email]@med.nagoya-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Surgery II, Nagoya University Graduate School of Medicine, 63 Tsurumai-cho, Showa-ku, Japan. 2003 - 2011
  • Department of Gastroenterological Surgery, Aichi Cancer Centre, Nagoya, Japan. 2005

References

  1. A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). Kodera, Y., Imano, M., Yoshikawa, T., Takahashi, N., Tsuburaya, A., Miyashita, Y., Morita, S., Nakao, A., Sakamoto, J., Sasako, M. Jpn. J. Clin. Oncol. (2011) [Pubmed]
  2. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Kodera, Y., Ito, S., Mochizuki, Y., Kondo, K., Koshikawa, K., Suzuki, N., Kojima, H., Kojima, T., Matsui, T., Takase, T., Tsuboi, K., Fujiwara, M., Nakao, A. Eur. J. Surg. Oncol (2009) [Pubmed]
  3. Radical surgery for gastric carcinoma: it is not an issue of whether to perform D1 or D2. Dissect as many lymph nodes as possible and you will be rewarded. Kodera, E., Fujiwara, M., Ito, Y., Ohashi, N., Nakayama, G., Koike, M., Nakao, A. Acta Chir. Belg. (2009) [Pubmed]
  4. Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Kodera, Y., Nakanishi, H., Ito, S., Misawa, K., Ito, Y., Nakayama, G., Koike, M., Fujiwara, M., Yamamura, Y., Nakao, A. Anticancer Res. (2009) [Pubmed]
  5. The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma. Kodera, Y., Ito, S., Mochizuki, Y., Yamamura, Y., Misawa, K., Ohashi, N., Nakayama, G., Koike, M., Fujiwara, M., Nakao, A. World. J. Surg (2008) [Pubmed]
  6. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma. Kodera, Y., Ito, Y., Ito, S., Ohashi, N., Mochizuki, Y., Yamamura, Y., Koike, M., Fujiwara, M., Nakanishi, H., Nakao, A. Hepatogastroenterology (2007) [Pubmed]
  7. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil. Kodera, Y., Ito, S., Fujiwara, M., Mochizuki, Y., Nakayama, G., Ohashi, N., Koike, M., Yamamura, Y., Nakao, A. Cancer Lett. (2007) [Pubmed]
  8. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study). Kodera, Y., Ito, S., Mochizuki, Y., Fujitake, S., Koshikawa, K., Kanyama, Y., Matsui, T., Kojima, H., Takase, T., Ohashi, N., Fujiwara, M., Sakamoto, J., Akimasa, N. Anticancer Res. (2007) [Pubmed]
  9. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues. Kodera, Y., Ito, S., Fujiwara, M., Mochizuki, Y., Ohashi, N., Ito, Y., Nakayama, G., Koike, M., Yamamura, Y., Nakao, A. Int. J. Clin. Oncol. (2006) [Pubmed]
  10. Chemotherapy as a component of multimodal therapy for gastric carcinoma. Kodera, Y., Fujiwara, M., Koike, M., Nakao, A. World J. Gastroenterol. (2006) [Pubmed]
  11. Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts. Kodera, Y., Fujiwara, M., Yokoyama, H., Ohashi, N., Miura, S., Ito, Y., Koike, M., Ito, K., Nakao, A. In. Vivo (2005) [Pubmed]
  12. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Kodera, Y., Sasako, M., Yamamoto, S., Sano, T., Nashimoto, A., Kurita, A. Br. J. Surg (2005) [Pubmed]
  13. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Kodera, Y., Ito, S., Yamamura, Y., Mochizuki, Y., Fujiwara, M., Hibi, K., Ito, K., Akiyama, S., Nakao, A. Hepatogastroenterology (2004) [Pubmed]
  14. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Kodera, Y., Nakanishi, H., Ito, S., Mochizuki, Y., Yamamura, Y., Fujiwara, M., Hibi, K., Ito, K., Akiyama, S., Tatematsu, M., Nakao, A. Jpn. J. Clin. Oncol. (2004) [Pubmed]
  15. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Kodera, Y., Ito, S., Yamamura, Y., Mochizuki, Y., Fujiwara, M., Hibi, K., Ito, K., Akiyama, S., Nakao, A. Ann. Surg. Oncol. (2003) [Pubmed]
 
WikiGenes - Universities